Delivery Order SPE2DB20D2014-SPE2DB26FA21T
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,245.08 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 15 mg/0.5 mL pen injectors on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. The product will be delivered to the agency's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,762.72 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $10,128.30 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens. This is a firm fixed-price delivery order with a completion date of August 21, 2025, issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.96 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on August 21, 2025, with completion scheduled for August 22, 2025. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive selection. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery to support...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.56 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award to the qualified vendor. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,306.78 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and performance to be executed at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,537.40 on June 2, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $45,574.51 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors. The order was competitively awarded with no set-aside designation and is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $31,248.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on August 20, 2025, with completion targeted for August 21, 2025. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $26,814.30 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens with an ultimate completion date of September 11, 2025. This firm fixed price, non-competitive delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA21TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,643.44 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies pharmaceutical products and medical commodities to support military and veteran healthcare systems through its extensive contract portfolio with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current Zepbound order represents a typical delivery order issued against this expansive pharmaceutical support contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.6k | 10/29/25 |